Use of clonidine in children with autism spectrum disorders.
Children with autism spectrum disorders (ASD) often exhibit sleep and behavioral disorders. Treatment of sleep disorders can be difficult in these children. Clonidine, an alpha2-adrenergic receptor agonist, has been shown to be effective in reducing impulsivity, inattention, and hyperactivity, as well as in serving as a sedative for medial procedures. An open labeled retrospective study of clonidine in treatment of insomnia, and/or hyperactivity, inattention, mood disorder, and aggressive behaviors was conducted using parent reports of sleep initiation and maintenance, as well as behaviors prior and during clonidine treatment. Clonidine was effective in reducing sleep initiation latency and night awakening, to a less degree in improving attention deficits hyperactivity, mood instability and aggressiveness in this cohort of 19 children with ASD. The side effects were largely tolerable. Further evaluation with placebo-controlled double-blind clinical trial of clonidine use in ASD will provide more insight into the clinical efficacy and safety of the medicine in ASD.
Ming
Xue
X
Department of Neuroscience and Pediatrics, UMDNJ - New Jersey Medical School, 90 Bergen Street, Doctor's Office Center 8100, Newark, NJ 07103, USA. mingxu@umdnj.edu
Gordon
Emily
E
Kang
Ning
N
Wagner
George C
GC
D000293:Adolescent; D000316:Adrenergic alpha-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D000374:Aggression / Q000187:drug effects; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001294:Attitude to Health; D001321:Autistic Disorder / Q000188:drug therapy* / Q000523:psychology; D002648:Child; D002675:Child, Preschool; D003000:Clonidine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D007175:Impulsive Behavior / Q000188:drug therapy; D008297:Male; D019964:Mood Disorders / Q000188:drug therapy; D011569:Psychiatric Status Rating Scales; D012189:Retrospective Studies; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D012893:Sleep Wake Disorders / Q000188:drug therapy* / Q000523:psychology; D016896:Treatment Outcome
D000316:Adrenergic alpha-Agonists; D003000:Clonidine